Coherus BioSciences Inc. (CHRS) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Coherus BioSciences Inc.

NASDAQ: CHRS · Real-Time Price · USD
1.38
0.09 (6.98%)
At close: Sep 08, 2025, 2:22 PM

Coherus BioSciences Revenue

Coherus BioSciences reported an annual revenue of $266.96M, reflecting a 3.78% growth. For the quarter ending June 30, 2025, Coherus BioSciences generated $10.25M in revenue.
Revenue (ttm)
266.96M
Revenue Growth
3.78%
Price / Sales Ratio
0.59
Revenue / Employee
1.17M
Employees
228
Market Cap
159.81M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 266.96M +3.78%
Dec 31, 2023 257.24M +21.89%
Dec 31, 2022 211.04M -35.37%
Dec 31, 2021 326.55M -31.37%
Dec 31, 2020 475.82M +33.63%
Dec 31, 2019 356.07M +22783.74%
Dec 31, 2018 1.56M n/a
Dec 31, 2017 1.56M -99.18%
Dec 31, 2016 190.11M +532.82%
Dec 31, 2015 30.04M -3.42%
Dec 31, 2014 31.11M +1030.72%
Dec 31, 2013 2.75M +44.87%
Dec 31, 2012 1.9M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.